These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 1356095)

  • 41. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
    J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway.
    Ting AT; Einspahr KJ; Abraham RT; Leibson PJ
    J Immunol; 1991 Nov; 147(9):3122-7. PubMed ID: 1833464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
    Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
    Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes.
    Clark MR; Stuart SG; Kimberly RP; Ory PA; Goldstein IM
    Eur J Immunol; 1991 Aug; 21(8):1911-6. PubMed ID: 1831131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The glycosylphosphatidylinositol-linked Fc gamma receptor III represents the dominant receptor structure for immune complex activation of neutrophils.
    Hundt M; Schmidt RE
    Eur J Immunol; 1992 Mar; 22(3):811-6. PubMed ID: 1532149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
    Littaua R; Kurane I; Ennis FA
    J Immunol; 1990 Apr; 144(8):3183-6. PubMed ID: 2139079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity of two types of Fc receptors, Fc gamma RI and Fc gamma RII, in human monocyte cytotoxicity to sensitized erythrocytes.
    van de Winkel JG; Boonen GJ; Janssen PL; Vlug A; Hogg N; Tax WJ
    Scand J Immunol; 1989 Jan; 29(1):23-31. PubMed ID: 2522235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro.
    Varin N; Sautès C; Galinha A; Even J; Hogarth PM; Fridman WH
    Eur J Immunol; 1989 Dec; 19(12):2263-8. PubMed ID: 2532600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of CD16+dim and CD16+bright lymphocytes--comparison of peripheral and clonal non-MHC-restricted T cells and NK cells.
    Uciechowski P; Werfel T; Leo R; Gessner JE; Schubert J; Schmidt RE
    Immunobiology; 1992 Jun; 185(1):28-40. PubMed ID: 1398740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
    Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
    Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII.
    Bakács T; Hadley AG; Kumpel BM; Segal DM; Banhidy F
    Immunol Lett; 1994 Sep; 42(1-2):91-5. PubMed ID: 7829136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
    Kumpel BM; Hadley AG
    Mol Immunol; 1990 Mar; 27(3):247-56. PubMed ID: 2111455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Granulocyte Fc gamma receptor recognition of cell bound and aggregated IgG: effect of gamma-interferon.
    Ruiz P; Gomez F; Lopez R; Chien P; Rossman MD; Schreiber AD
    Am J Hematol; 1992 Apr; 39(4):257-63. PubMed ID: 1532472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors.
    Greenman J; Tutt AL; George AJ; Pulford KA; Stevenson GT; Glennie MJ
    Mol Immunol; 1991 Nov; 28(11):1243-54. PubMed ID: 1835758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.
    Greenman J; Hogg N; Nikoletti S; Slade C; Stevenson G; Glennie M
    Cancer Immunol Immunother; 1992; 34(6):361-9. PubMed ID: 1532922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Fc gamma RI triggering of the mononuclear phagocyte respiratory burst.
    Pound JD; Lund J; Jefferis R
    Mol Immunol; 1993 Apr; 30(5):469-78. PubMed ID: 8385266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.
    Preithner S; Elm S; Lippold S; Locher M; Wolf A; da Silva AJ; Baeuerle PA; Prang NS
    Mol Immunol; 2006 Mar; 43(8):1183-93. PubMed ID: 16102830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
    Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
    J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.